Maintaining bone health in patients with multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinical Journal of Oncology Nursing

• Publication date

  2011-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1188/11.S1.CJON.9-23PMID 21816707PMCID PMC4189925
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myeloma bone disease: Pathophysiology and management

  2013cited by this paper
• Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules.

  2013cited by this paper
• Renal complications in multiple myeloma and related disorders: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.

  2011cited by this paper
• Fast Facts on Osteoporosis

  2011cited by this paper
• Mobility and safety in the multiple myeloma survivor: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.

  2011cited by this paper
• Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial.

  2011cited by this paper
• Managing the adverse effects of radiation therapy.

  2010cited by this paper
• First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

  2010cited by this paper
• F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma.

  2009cited by this paper
• Consolidation Therapy with Bortezomib, Thalidomide and Dexamethasone (VTD) Regimen After ASCT in Myeloma Patients Who Do Not Receive Bisphosphonates Reduces Bone Resorption and RANKL/OPG Ratio but Seems to Have No Effect On Bone Formation and Angiogenesis.

  2009cited by this paper
• Myeloma bone disease: recent advances in biology, diagnosis, and treatment.

  2009cited by this paper
• Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors.

  2009cited by this paper
• Bone health in diabetes: considerations for clinical management.

  2009cited by this paper
• The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo

  2009cited by this paper
• A new pet for myeloma.

  2009cited by this paper
• Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.

  2009influential reference
• Spontaneous fracture: multiple causes.

  2009cited by this paper
• Skeletal imaging and management of bone disease.

  2008cited by this paper
• Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates

  2008cited by this paper
• Depression, antidepressants, and bone mineral density in a population-based cohort.

  2008cited by this paper
• Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma

  2008cited by this paper
• African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox.

  2008cited by this paper
• Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: definition and management of the risk related to zoledronic acid.

  2008cited by this paper
• Bisphosphonate therapy for metastatic bone disease: the pivotal role of nurses in patient education.

  2008cited by this paper
• Steroid-associated side effects in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board.

  2008cited by this paper
• Calcifications in the Abdominal Aorta Predict Fractures in Men: MINOS Study

  2007cited by this paper
• American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma.

  2007cited by this paper
• The 25-hydroxyvitamin D threshold for better health.

  2007influential reference
• Epidemiology of the plasma-cell disorders.

  2007cited by this paper
• Depression and osteoporosis: epidemiology and potential mediating pathways

  2007cited by this paper
• Diet, nutrition, and bone health.

  2007influential reference
• Supportive care in multiple myeloma.

  2007cited by this paper
• Use of bisphosphonates in multiple myeloma: IMWG response to Mayo Clinic consensus statement.

  2007cited by this paper
• Pathophysiology of myeloma bone disease.

  2007cited by this paper
• Bone loss and fracture risk associated with cancer therapy.

  2006influential reference
• Vitamin C Inactivates the Proteasome Inhibitor PS-341 in Human Cancer Cells

  2006cited by this paper
• Bone complications in multiple myeloma

  2006cited by this paper
• Myeloma and bone disease: "the dangerous tango".

  2006cited by this paper
• Dietary Approaches that Delay Age-Related Diseases

  2006influential reference
• Treatment for Myeloma Bone Disease

  2006cited by this paper
• Diagnosis, screening, prevention, and treatment of osteoporosis.

  2006influential reference
• The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.

  2006cited by this paper
• Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity

  2006cited by this paper
• Solitary bone and extramedullary plasmacytoma.

  2005cited by this paper
• Complications of chronic kidney disease: a close look at renal osteodystrophy, nutritional disturbances, and inflammation.

  2005cited by this paper
• Myeloma bone disease: pathophysiology and management.

  2005cited by this paper
• The changing treatment paradigm in patients with newly diagnosed multiple myeloma: implications for nursing.

  2005cited by this paper
• Part 1: Surgical palliation of advanced illness--what's new, what's helpful.

  2005cited by this paper
• International staging system for multiple myeloma.

  2005cited by this paper
• Fracture Risk With Multiple Myeloma: A Population‐Based Study

  2004cited by this paper
• Bone metabolism in patients more than five years after bone marrow transplantation

  2004cited by this paper
• Multiple myeloma: clinical review and diagnostic imaging.

  2004cited by this paper
• Mechanisms of bone metastasis.

  2004cited by this paper
• Mechanisms of bone metastasis.

  2004cited by this paper
• Review of 1027 patients with newly diagnosed multiple myeloma.

  2003cited by this paper
• Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

  2003cited by this paper
• Advances in supportive care of patients with cancer and bone metastases: nursing implications of zoledronic acid.

  2003cited by this paper
• The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells.

  2002cited by this paper
• Intramedullary spread of tumour cells during IM nailing: a histological diagnosis

  2002cited by this paper
• Osteoporosis and Diabetes

  2002cited by this paper
• The skeletal site-differential changes in bone mineral density following bone marrow transplantation: 3-year prospective study.

  2002cited by this paper
• Metastatic bone disease: clinical features, pathophysiology and treatment strategies.

  2001cited by this paper
• Radiotherapy in the management of plasma cell tumors.

  2000cited by this paper
• Bisphosphonates in multiple myeloma

  2000cited by this paper
• The short-term changes of bone mineral metabolism following bone marrow transplantation.

  2000cited by this paper
• The Effect of Exercise Training Programs on Bone Mass: A Meta-analysis of Published Controlled Trials in Pre- and Postmenopausal Women

  1999cited by this paper
• Prognostic value of vertebral lesions detected by magnetic resonance imaging in patients with stage I multiple myeloma

  1999cited by this paper
• Mechanisms of Bone Loss Following Allogeneic and Autologous Hemopoietic Stem Cell Transplantation

  1999cited by this paper
• Endocrine function and bone metabolism 5 years after autologous bone marrow/blood‐derived progenitor cell transplantation

  1997cited by this paper
• Endocrine function and bone metabolism 5 years after autologous bone marrow/blood-derived progenitor cell transplantation.

  1997cited by this paper
• Management of bone metastases.

  1997cited by this paper
• Oncologic imaging: interactions of nuclear medicine with CT and MRI using the bone scan as a model.

  1997cited by this paper
• Pharmacologic treatment of cancer pain.

  1996cited by this paper
• Management of bone metastases.

  1995cited by this paper
• Computed tomography in diagnosis and management of multiple myeloma and its variants.

  1985cited by this paper
• A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

  1975cited by this paper
• Multiple myeloma.

  1948cited by this paper

• Onco-Hem Connectome-Network-Based Phenotyping of Polypharmacy and Drug-Drug Interactions in Onco-Hematological Inpatients.

  2026cites this paper
• Tailored psychoeducation for multiple myeloma patients: a step toward enhancing quality of life and health outcomes.

  2026cites this paper
• Automated vertebrae identification and segmentation with structural uncertainty analysis in longitudinal CT scans of patients with multiple myeloma.

  2025cites this paper
• Clinical-Paraclinical Features of Multiple Myeloma with Bone Affection

  2025influential citation
• Hip Hemiarthroplasty in Patients with Multiple Myeloma: A Retrospective Case Series and Review of the Literature

  2024cites this paper
• Adherence to the evidence-based recommendations in managing bone health, pain, and mobility of patients with multiple myeloma: a mixed method in the Palestinian healthcare system

  2024cites this paper
• Management of atraumatic chin-on-chest deformity in newly diagnosed multiple myeloma: illustrative case

  2024cites this paper
• Expert consensus on a multidisciplinary approach for the management of multiple myeloma-related bone disease

  2024cites this paper
• The Global Prevalence of Vitamin D Deficiency and Insufficiency in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis

  2023cites this paper
• Preventing osteolytic lesions and osteomyelitis in multiple myeloma

  2022cites this paper
• FDA-approved bone grafts and bone graft substitute devices in bone regeneration.

  2021cites this paper
• Current practice patterns of osteoporosis treatment in cancer patients and effects of therapeutic interventions in a tertiary center

  2021cites this paper
• Nutritional Supplements and Complementary/Alternative Medications in Patients With Hematologic Diseases and Hematopoietic Stem Cell Transplantation.

  2021cites this paper
• Surgical Management of Multiple Myeloma and Plasmocytoma of the Spine

  2020cites this paper
• Physical activity is associated with less comorbidity, better treatment tolerance and improved response in patients with multiple myeloma undergoing stem cell transplantation.

  2020cites this paper
• The Biological Activities of Oleocanthal from a Molecular Perspective

  2018cites this paper
• Naringenin inhibits osteoclastogenesis through modulation of helper T cells‐secreted IL‐4

  2018cites this paper
• Barriers and Facilitators of Using Sensored Medication Adherence Devices in a Diverse Sample of Patients With Multiple Myeloma: Qualitative Study

  2018cites this paper
• Myelosuppression, Bone Disease, and Acute Renal Failure: Evidence‐based recommendations for oncologic emergencies

  2017cites this paper
• Bone Health, Pain, and Mobility: Evidence‐based recommendations for patients with multiple myeloma

  2017influential citation
• Disease and Symptom Care: A Focus on Specific Needs of Patients With Multiple Myeloma
.

  2017cites this paper
• Multiple Myeloma: The Role of the Primary Care Nurse Practitioner

  2017cites this paper
• Evidence-Based Guidelines for Preventing and Managing Side Effects of Multiple Myeloma.

  2017cites this paper
• Strategies for Selecting the Optimal Treatment in Newly Diagnosed Multiple Myeloma Patients.

  2017cites this paper
• Guidelines for screening and management of late and long‐term consequences of myeloma and its treatment

  2017cites this paper
• Assessment and monitoring of patients receiving chemotherapy for multiple myeloma: strategies to improve outcomes Blood and Lymphatic Cancer: Targets and Therapy

  2016cites this paper
• Assessment and monitoring of patients receiving chemotherapy for multiple myeloma: strategies to improve outcomes

  2016cites this paper
• Clinical perspective: Linking psychosocial care to the disease continuum in patients with multiple myeloma*

  2014cites this paper
• Identifying professional education gaps and barriers in multiple myeloma patient care: findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee.

  2014cites this paper
• Exercise is medicine: case report of a woman with smoldering multiple myeloma.

  2013cites this paper
• Promoting quality of life for patients with myeloma

  2013influential citation
• Autologous hematopoietic stem cell transplantation for patients with multiple myeloma: an overview for nurses in community practice.

  2013cites this paper
• Treatment options for myeloma.

  2013cites this paper
• Routine health maintenance in patients living with multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.

  2011cites this paper
• Renal complications in multiple myeloma and related disorders: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.

  2011cites this paper
• It takes a village ( of therapies ) to achieve optimal long-term outcomes for multiple myeloma

  year unknowncites this paper
• The burden of living with myeloma and the challenges of coping with treatment Myeloma

  year unknowncites this paper
• W Bone Health, Pain, and Mobility Evidence-based recommendations for patients with multiple myeloma

  year unknowninfluential citation